US Patent 11479755 T cell compositions
Patent 11479755 was granted and assigned to 2seventy bio, Inc. on October, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Kevin Friedman0
Edits on 26 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 23 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 6 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 29 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 24 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 23 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 28 Oct, 2022
Golden AI
Edits made to:
Infobox (+18 properties)
Article (+271 characters)
US Patent 11479755 T cell compositions
Article
The invention provides improved T cell compositions and methods for manufacturing T cells. More particularly, the invention provides methods of T cell manufacturing that result in adoptive T cell immunotherapies with improved survival, expansion, and persistence in vivo.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114797550
Date of Patent
October 25, 2022
0Patent Application Number
160601840
Date Filed
December 7, 2015
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11479755 T cell compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.